Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

Human Evolution: Between Hemorrhage and Thrombosis.

Seminars in thrombosis and hemostasis·2026

Same author

<i>YoyoMut</i>: Interactive Exploration of SARS-CoV-2 Mutation Fixation and Reversion Through Time.

Life (Basel, Switzerland)·2026

Same author

TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses.

Vaccines·2026

Same author

On the Use of Immunoglobulins for Pre-exposure Prophylaxis Against COVID-19 in Immunocompromised Patients.

Infection and drug resistance·2026

Same author

Metabolic determinants of torque teno virus load across the diabetes spectrum: insights from a cross-sectional analysis.

Scientific reports·2026

Same author

COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.

Expert review of anti-infective therapy·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

Catastrophic Thrombosis: A Narrative Review.

Massimo Franchini¹, Daniele Focosi², Mario Piergiulio Pezzo¹

¹Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy.

Seminars in Thrombosis and Hemostasis

|August 16, 2024

Summary

Catastrophic thrombosis involves widespread blood clots and is a medical emergency. Early recognition and treatment of underlying causes alongside anticoagulation are crucial for patient survival.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Experiment Videos

Last Updated: Jun 16, 2025

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots

Published on: July 21, 2023

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Area of Science:

Hematology
Critical Care Medicine
Internal Medicine

Background:

Catastrophic thrombosis is a rare but life-threatening condition characterized by a hypercoagulable state and multiple thromboembolic events.
It is associated with diverse conditions including catastrophic antiphospholipid syndrome, thrombotic microangiopathies, cancers, and infections.
Thrombotic storm necessitates urgent medical intervention and poses significant management challenges.

Purpose of the Study:

To review the main characteristics of catastrophic thrombosis.
To analyze the various conditions that can trigger this severe complication.
To present a diagnostic and initial management algorithm for affected patients.

Main Methods:

This study is a narrative review.
It synthesizes information on the pathophysiology and clinical presentation of catastrophic thrombosis.
An algorithm for diagnosis and management is proposed.

Main Results:

Catastrophic thrombosis presents with a hypercoagulable tendency and rapid onset of multiple thromboembolic events.
Associated conditions are varied, highlighting the need for a broad differential diagnosis.
Prompt anticoagulation and identification/treatment of the underlying cause are key to improving prognosis.

Conclusions:

Catastrophic thrombosis is a critical medical emergency requiring swift and comprehensive management.
Early diagnosis and targeted treatment of precipitating factors are essential for patient outcomes.
The proposed algorithm aims to guide physicians in the workup and initial treatment of this condition.